Bilimsel çalışmalar

Dr. Berkay Yeşilyurt

14 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)

    Cancers, 2026

    DOI 10.3390/cancers18030394 PMID 41681877 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  2. Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy

    International journal of urology : official journal of the Japanese Urological Association, 2026

    DOI 10.1111/iju.70619 PMID 42655932 Açık erişimli tam metinKaynak: Europe PMC

  3. Long-term Outcomes and Prognostic Factors in Chordoma: A 20-year Single-center Experience

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2025-11-6 Açık erişimli tam metinKaynak: OpenAlex

  4. Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma

    Future oncology (London, England), 2026

    DOI 10.1080/14796694.2026.2732589 PMID 42730632 Kaynak: Europe PMC

  5. Timing of Second-Line Nivolumab and Survival in Metastatic Renal Cell Carcinoma

    Clinical Genitourinary Cancer, 2026

    DOI 10.1016/j.clgc.2026.102653 PMID 42700745 Kaynak: OpenAlex

  6. Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study

    Medicina, 2026

    DOI 10.3390/medicina62050992 PMID 42195245 Açık erişimli tam metinKaynak: ORCID

  7. Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO)

    JCO global oncology, 2026

    DOI 10.1200/go-25-00655 PMID 41886718 Açık erişimli tam metinKaynak: Europe PMC

  8. Impact of radiologically identified embryological origin on recurrence patterns and survival in resectable pancreatic head adenocarcinoma.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.4228 Kaynak: OpenAlex

  9. Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study ( TOG / GI ‐ SAFRADJU ‐2501)

    International Journal of Cancer, 2026

    DOI 10.1002/ijc.70623 PMID 42372083 Açık erişimli tam metinKaynak: OpenAlex

  10. HALP–GRIms Synergy Offers Superior Prognostic and Predictive Precision in Advanced Pancreatic Ductal Adenocarcinoma

    Research Square, 2025

    DOI 10.21203/rs.3.rs-7277845/v1 Açık erişimli tam metinKaynak: OpenAlex

  11. Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction

    European Journal of Internal Medicine, 2023

    DOI 10.1016/j.ejim.2023.05.021 PMID 37217407 12 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  12. Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic

    Supportive Care in Cancer, 2021

    DOI 10.1007/s00520-020-05927-7 PMID 33404804 7 atıf (Europe PMC) Kaynak: ORCID

  13. Clinical Characteristics and Outcome of ANCA-Associated Vasculitis; Experience of A Single Reference Vasculitis Center

    Acta Medica, 2020

    DOI 10.32552/2020.actamedica.509 Açık erişimli tam metinKaynak: OpenAlex

  14. 1505MO Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.131 Açık erişimli tam metinKaynak: OpenAlex